Posted: 8 July 2026 - London, United Kingdom
This postdoctoral position involves identifying therapeutic antigen targets for antibody-based treatment of inflammatory bowel disease (IBD). The project leverages regulatory T cells to develop precision medicine strategies for IBD patients. The successful candidate will map immune subtype gene expression, validate findings in gut tissue, and apply spatial proteomics. This role offers an opportunity to build an independent research profile while collaborating with experts in the field.